Methylnaltrexone for the management of unwanted peripheral opioid effects

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.4, 2008-07, pp. : 531-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endocrine effects of chronic opioid therapy: implications for clinical management

By Elliott Jennifer A Fibuch Eugene E

Pain Management, Vol. 3, Iss. 3, 2013-05 ,pp. : 237-246

Future Medicine

Access to resources Recommend Favorite

The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 693-704

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid‐Induced Constipation: A Responder Analysis of 2 Randomized, Placebo‐Controlled Trials

PAIN PRACTICE, Vol. 15, Iss. 6, 2015-07 ,pp. : 564-571

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiac Effects of Opioid Therapy

PAIN MEDICINE, Vol. 16, Iss. S1, 2015-10 ,pp. : S27-S31

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effect of Methylnaltrexone on the Side Effects of Intrathecal Morphine after Orthopedic Surgery under Spinal Anesthesia

PAIN PRACTICE, Vol. 15, Iss. 4, 2015-04 ,pp. : 348-354

John Wiley & Sons Inc

Access to resources Recommend Favorite